Evelyn Partners’s Amgen AMGN Stock Holding History

Evelyn Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$55.6K	Buy	132 +19	+17%	+$7.57K	﹤0.01%	417
2026 Q2	$40.9K	Buy	+113	New	+$38.7K	﹤0.01%	387

Other funds holding AMGN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Evelyn Partners's AMGN Position: Q3 2026 in Review

Evelyn Partners increased its Amgen (AMGN) stake by 17% in Q3 2026, buying an estimated $7.57K and bringing the position to 132 shares worth $55.6K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Evelyn Partners first reported a position in AMGN in Q2 2026 and has held it in 2 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Evelyn Partners held 132 shares of Amgen worth $55.6K as of Q3 2026.
Evelyn Partners bought 19 Amgen shares in Q3 2026, an estimated $7.57K.
Amgen made up ﹤0.01% of Evelyn Partners's portfolio in Q3 2026, its #417 holding.
Evelyn Partners first reported a position in Amgen in Q2 2026 and has held it in 2 quarters since.
2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.